Mytrex Health Technologies, Inc.
Mytrex Health Technologies, Inc. engages in the manufacturing, processing, and sale of various filter non-woven fabrics in Taiwan, rest of Asia, Europe, and internationally. The company provides electrostatic filtration materials for medical and industrial mask media, and other filtration applications; and composite nonwoven products for coolant and air filter, vacuum filter bag, HEPA and cabin f… Read more
Mytrex Health Technologies, Inc. (4431) - Net Assets
Latest net assets as of June 2025: NT$596.12 Million TWD
Based on the latest financial reports, Mytrex Health Technologies, Inc. (4431) has net assets worth NT$596.12 Million TWD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (NT$1.14 Billion) and total liabilities (NT$544.57 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | NT$596.12 Million |
| % of Total Assets | 52.26% |
| Annual Growth Rate | 12.84% |
| 5-Year Change | -37.47% |
| 10-Year Change | N/A |
| Growth Volatility | 82.21 |
Mytrex Health Technologies, Inc. - Net Assets Trend (2019–2024)
This chart illustrates how Mytrex Health Technologies, Inc.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Mytrex Health Technologies, Inc. (2019–2024)
The table below shows the annual net assets of Mytrex Health Technologies, Inc. from 2019 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | NT$609.31 Million | -10.06% |
| 2023-12-31 | NT$677.47 Million | -29.99% |
| 2022-12-31 | NT$967.70 Million | +15.81% |
| 2021-12-31 | NT$835.57 Million | -14.25% |
| 2020-12-31 | NT$974.43 Million | +192.59% |
| 2019-12-31 | NT$333.04 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Mytrex Health Technologies, Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 229.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | NT$365.36 Million | 60.88% |
| Other Components | NT$356.74 Million | 59.44% |
| Total Equity | NT$600.17 Million | 100.00% |
Mytrex Health Technologies, Inc. Competitors by Market Cap
The table below lists competitors of Mytrex Health Technologies, Inc. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
TAS Offshore Bhd
KLSE:5149
|
$7.76 Million |
|
Rambler Metals and Mining PLC
PINK:RBMTF
|
$7.76 Million |
|
Baru Gold Corp
OTCQB:BARUF
|
$7.76 Million |
|
MCKESSON - Dusseldorf Stock Exchang
DU:MCK
|
$7.76 Million |
|
EITA Resources Bhd
KLSE:5208
|
$7.75 Million |
|
Thai Parcels Public Company Limited
BK:TPL
|
$7.75 Million |
|
RUGBY RESOURCES LTD
F:64O
|
$7.75 Million |
|
Nuenergy Gas Ltd
AU:NGY
|
$7.75 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Mytrex Health Technologies, Inc.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 674,844,000 to 600,174,000, a change of -74,670,000 (-11.1%).
- Net loss of 82,375,000 reduced equity.
- Other comprehensive income increased equity by 14,943,000.
- Other factors decreased equity by 7,238,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | NT$-82.38 Million | -13.73% |
| Other Comprehensive Income | NT$14.94 Million | +2.49% |
| Other Changes | NT$-7.24 Million | -1.21% |
| Total Change | NT$- | -11.06% |
Book Value vs Market Value Analysis
This analysis compares Mytrex Health Technologies, Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.15x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 1.79x to 1.15x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | NT$10.51 | NT$18.85 | x |
| 2020-12-31 | NT$29.56 | NT$18.85 | x |
| 2021-12-31 | NT$22.82 | NT$18.85 | x |
| 2022-12-31 | NT$26.40 | NT$18.85 | x |
| 2023-12-31 | NT$18.47 | NT$18.85 | x |
| 2024-12-31 | NT$16.39 | NT$18.85 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Mytrex Health Technologies, Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -13.73%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -4.68%
- • Asset Turnover: 1.54x
- • Equity Multiplier: 1.91x
- Recent ROE (-13.73%) is below the historical average (0.96%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | 2.80% | 2.34% | 0.98x | 1.22x | NT$-23.99 Million |
| 2020 | 36.22% | 34.41% | 0.77x | 1.36x | NT$255.03 Million |
| 2021 | -1.68% | -4.80% | 0.31x | 1.14x | NT$-97.38 Million |
| 2022 | -9.53% | -6.25% | 0.99x | 1.54x | NT$-188.36 Million |
| 2023 | -8.33% | -4.35% | 1.03x | 1.86x | NT$-123.70 Million |
| 2024 | -13.73% | -4.68% | 1.54x | 1.91x | NT$-142.39 Million |
Industry Comparison
This section compares Mytrex Health Technologies, Inc.'s net assets metrics with peer companies in the Specialty Industrial Machinery industry.
Industry Context
- Industry: Specialty Industrial Machinery
- Average net assets among peers: $13,532,689,500
- Average return on equity (ROE) among peers: 12.35%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Mytrex Health Technologies, Inc. (4431) | NT$596.12 Million | 2.80% | 0.91x | $7.76 Million |
| TECO Electric & Machinery Co Ltd (1504) | $61.70 Billion | 5.22% | 0.61x | $3.79 Billion |
| Chung-Hsin Electric & Machinery Mfg Corp (1513) | $19.24 Billion | 18.82% | 1.56x | $1.96 Billion |
| Anderson Industrial Corp (1528) | $2.30 Billion | -6.77% | 1.31x | $87.63 Million |
| Awea Mechantronic Co Ltd (1530) | $3.16 Billion | 4.15% | 0.97x | $20.63 Million |
| Kaulin Mfg (1531) | $4.60 Billion | 7.11% | 0.29x | $39.04 Million |
| Chiu Ting Machinery Co Ltd (1539) | $990.48 Million | 22.54% | 1.99x | $14.13 Million |
| Roundtop Machinery Industries Co Ltd (1540) | $1.20 Billion | 23.81% | 0.57x | $45.90 Million |
| Sinmag Equipment (1580) | $2.98 Billion | 20.23% | 0.34x | $131.61 Million |
| Goodway Machine Corp (1583) | $4.00 Billion | 10.09% | 1.15x | $28.04 Million |
| Airtac International Group (1590) | $35.15 Billion | 18.33% | 0.36x | $3.89 Billion |